Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06994325

Testing the CHAT Program for Patients With Heart Failure

A Pilot Hybrid Effectiveness-Implementation Trial for the Conversations Helpful for Awareness of Illness Trajectory (CHAT) Intervention

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The researchers are studying whether an intervention that involves video-based educational content and a health coach is acceptable, feasible, and effective for people with Heart Failure with Preserved Ejection Fraction (HFpEF).

Detailed description

This is a pilot randomized controlled trial of 50 subjects that will compare the CHAT intervention (video-based educational content and a health coach) with usual care. Video-based educational content was developed based on Adult Learning Theory and Social Cognitive Theory. Key content areas covered by the videos and health coach will include: HFpEF Overview, Signs and Symptoms of HFpEF, Medication Management, Physical Activity and Diet with HFpEF, and Planning for the Future (Advance Care Planning).

Conditions

Interventions

TypeNameDescription
BEHAVIORALConversations Helpful for Awareness of Illness Trajectory (CHAT) InterventionThe Conversations Helpful for Awareness of illness Trajectory (CHAT) intervention will incorporate 4 health-coach sessions, supplemented by 7 educational videos. Each session will be up to 60 minutes long and will be conducted remotely. During the health coach sessions, a trained health coach will work with subjects, reviewing the content of each video and emphasizing key learning content.
BEHAVIORALStandard of Care (SOC)The Standard of Care Group will not have access to the Health Coach or video-based educational content. This group will have no study activities during Weeks 1-7 but will participate in follow-up assessments.

Timeline

Start date
2025-07-31
Primary completion
2026-07-11
Completion
2026-07-11
First posted
2025-05-29
Last updated
2026-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06994325. Inclusion in this directory is not an endorsement.